The Rockefeller University launches new biomedical startup incubator
Something new is coming to the south side of The Rockefeller University campus this fall: the Ford Center Incubator. Part of the Ford Center for Life Science Innovation, the incubator—a light, bright, 8,000-square-foot space on the newly renovated fourth floor of the Bronk Laboratory building—will be the first facility of its kind on the Upper […]
UK, partners awarded ‘Build to Scale’ grant to support Kentucky startups, diversify investors
LEXINGTON, Ky. (Dec. 4, 2023) — The University of Kentucky and its partners are one of 60 programs awarded “Build to Scale” grants from the U.S. Department of Commerce. Sixty organizations in 36 states, the District of Columbia and Puerto Rico were awarded. In total, $53 million will fund programs that support technology entrepreneurs, catalyze innovation and […]
New venture fund aims to further Notre Dame’s mission through purpose-driven startups
A new venture capital fund to advance the commercialization of University of Notre Dame and South Bend area innovations has reached a key milestone. Indianapolis-based High Alpha Innovation has successfully closed the first $17.5 million of the “1842 Fund,” named for the year Notre Dame was founded. The fund, which will support faculty research, student innovations and community startups […]
Ohio State University faculty innovators earn Accelerator Awards funding for novel technology commercialization
College of Engineering faculty L. Raymond Cao and Jordan D. Clark are among the five innovative minds selected to receive funding via The Ohio State University Accelerator Awards. The Accelerator Awards program is designed to advance the translation of technologies developed at Ohio State into the marketplace. The program provides grants of up to $150,000 per project […]
Biden administration asserts power to seize drug patents-citing march-in rights and Bayh-Dole Act
The Biden administration on Thursday opened the door to seizing the patents of certain costly medications from drugmakers in a new push to slash high drug prices and promote more pharmaceutical competition. The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, to take patents for drugs developed […]